Publication | Closed Access

Improved quality of life after long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer

Bone DiseaseBone HealthOncologyLong-term TreatmentBisphosphonate IbandronateBreast CancerMetastatic Bone DiseaseMetabolic Bone DiseaseMedicineRadiation OncologyOsteoporosisOrthopaedic Surgery